Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials 由 Reith, C

Epidemiological data on the use of traditional anticoagulants in cardiovascular disease 由 Reith, C, Baigent, C

Individual participant data meta-analysis of new-onset and worsening diabetes mellitus in large-scale randomized double-blind trials of statin therapy 由 Preiss, D, Reith, C

Protocol for analyses of adverse event data from randomized controlled trials of statin therapy 由 Mihaylova, B, Reith, C

Randomized clinical trials--removing obstacles. 由 Reith, C, Landray, M, Califf, R

Accelerating clinical trials: time to turn words into action 由 Landray, MJ, Haynes, R, Reith, C

Randomized clinical trials--removing obstacles. 由 Reith, C, Landray, M, Califf, R

Pharmacogenomics of statin therapy: any new insights in efficacy or safety? 由 Hopewell, J, Reith, C, Armitage, J

Lipid-modifying agents, from statins to PCSK9 inhibitors: JACC focus seminar 由 Preiss, D, Tobert, JA, Hovingh, GK, Reith, C

Lipid-modifying agents, from statins to PCSK9 inhibitors 由 Preiss, D, Tobert, J, Hovingh, G, Reith, C

Benefits of lowering cholesterol in chronic kidney disease Reply 由 Baigent, C, Landray, M, Reith, C, Emberson, J, Collins, R

Angiotensin receptor blockers and β-blockers in Marfan syndrome: an individual-patient-data meta-analysis of randomised trials 由 Pitcher, A, Spata, E, Emberson, J, Baigent, C, Reith, C

A pragmatic tool for drug discovery 由 Bobbitt, DR, Merson, L, Reith, C, Bao, W, Okada, M, Facile, R

Assessing baseline medication use in chronic kidney disease: An analysis of the SHARP-ER study 由 Jun, M, Sukkar, L, Jardine, M, Talbot, B, Cass, A, Reith, C, Walker, R, Gallagher, M

Use of causal diagrams to inform the analysis and interpretation of observational studies: An example from the Study of Heart and Renal Protection (SHARP) 由 Staplin, N, Herrington, W, Judge, P, Reith, C, Haynes, R, Landray, M, Baigent, C, Emberson, J

Randomized clinical trials--removing unnecessary obstacles. 由 Reith, C, Landray, M, Devereaux, P, Bosch, J, Granger, C, Baigent, C, Califf, R, Collins, R, Yusuf, S

Efficacy and safety of statin therapy in older people: meta-analysis of individual participant data from 28 randomised controlled trials 由 Cholesterol Treatment Trialists' Collaboration, Armitage, J, Collins, R, Baigent, C, Barnes, E, Emberson, J, Mihaylova, B, Reith, C

Cost-effectiveness of lowering LDL cholesterol with statins and ezetimibe in chronic kidney disease 由 Mihaylova, B, Kent, S, Herrington, W, Emberson, J, Haynes, R, Reith, C, Collins, R, Landray, M, Gray, A, Baigent, C

Cause of death varies across Australia, New Zealand and Malaysia in those on renal replacement therapy - Results from the Study of Heart And Renal Protection-Extended Review (SHARP... 由 Talbot, B, Sukkar, L, Smyth, B, Jun, M, Jardine, M, Cass, A, Walker, R, Reith, C, Hooi, L, Gallagher, M

Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials 由 Staplin, N, Roddick, AJ, Emberson, J, Reith, C, Riding, A, Wonnacott, A, Kuverji, A, Bhandari, S, Baigent, C, Haynes, R, Herrington, WG